Orchids & Onions Modesty spoke louder than monuments in this years crop of Orchids and Onions, San Diegos versions of the Oscars and Razzies for the built ... Nov 16, 2009
Bucking the jurys antipathy to big projects, the Peoples Choice Orchid Award went to the ResMed corporate headquarters in Serra Mesa ... ResMed corporate headquarters, 9001 Spectrum Center Blvd., Serra Mesa: ResMed, developer; KMA Architecture and Engineering and Davis Davis Architects. (San Diego Union-Tribune)
Watchful Argus has eyes for an improving market Nov 14, 2009
Resmed Peter Farrell. Legend Corp Bradley Dowe. (Sydney Morning Herald -- Business)
Orchid award goes to tiny eatery, onion to condo tower Nov 13, 2009
The public voted online for the ResMed corporate headquarters in San Diego's Serra Mesa neighborhood to be the People's Choice Orchid Award and a proposed casino in Jamul to be the People's Choice Onion. The 24 awards 15 Orchids and nine Onions were handed out at the On Broadway venue in the John D. Spreckels Building at Sixth and Broadway downtown. (San Diego Union-Tribune)
ResMed Profit Rises 50% on Demand for Sleep Disorder Treatment Equipment Nov 6, 2009
ResMed First-Quarter Profit Rises 50% on U.S. Demand (Update1) - Bloomberg ... ResMed First-Quarter Profit Rises 50% on U.S. Demand (Update1) ... ResMed shares advanced as much as 4. (Bloomberg -- Australia & New Zealand)
When the buck charges, world of markets turns bullish Oct 17, 2009
They include CSL, Ramsay Health Care, Resmed and SingTel. CSL has already started to warn its shareholders that the dollar will carve the froth off its earnings. (Sydney Morning Herald -- Business)
Sylvastate's profit slides Oct 1, 2009
" For the 2008-09 financial year Sylvastate reported an underlying operating profit after tax - and before fluctuations in capital value - of $2.664 million, down 26 per cent on the previous year. Investment revenue from its equities portfolio was down 25.7 per cent to $3.044 million. Sylvastate declared a final dividend of 10.5 cents per share, fully franked, taking the total dividend for the year to 21 cents and a 2.4 per cent improvement on 2007-08. The final dividend will be paid to... (Sydney Morning Herald -- Business)
Opportunities in the Obesity Epidemic Sep 2, 2009
And while the economic slump has hurt some medical companies, ResMed, a leading maker of sleep apnea devices, saw profits rise to $45. 4 million last quarter, 53% up over the same period last year. (BusinessWeek)
Rudd and Turnbull's standoff easier to fix than the planet's ills Aug 15, 2009
The sceptic was one of Australia's most successful entrepreneurs, Peter Farrell, founder of ResMed, a company that generates about $1billion a year selling treatments for sleep apnoea. Farrell believes that while climate change may be real, it's not because of human activity. (Sydney Morning Herald -- Opinion)
Oregon Rep. Fights Palin, Gingrich Attacks Aug 14, 2009
"My private health insurance just went up 40%. I guess they were "broke and running out of money". by ReallyMeanIt August 13, 2009 12:09 PM EDT Come on rev wright, give it a rest already. by speakinup22 August 13, 2009 1:13 PM EDT CBSName - I agree - healthcare is broken. It should not cost $190 for a ResMed CPAP Mask. But, having the government run the show will NOT make it efficient. What we need is for the public to be in the equation on having to pay for part of the service and products.... (CBS News -- US)
ResMed says well placed for future growth Aug 7, 2009
Sleep management company ResMed says it is well placed to continue growing, as the company booked annual net income of $US146 ... ResMed's revenue for the 2008/09 financial year rose 10 per cent, or 15 per cent on a constant currency basis, to $US920 ... "In the fourth quarter of fiscal 2009, we continued to show strong growth year over year," ResMed chief executive Kieran Gallahue said. (Sydney Morning Herald -- Business)
MICHAEL WEST Jul 8, 2009
ResMed is the archetypal case of a stock out of favour ... ResMed is so out of favour with the institutional market that it has fallen into the purview of corporate predators - while Centro is a goner. (Sydney Morning Herald -- Business)
Free nutrition workshop in Carlsbad May 21, 2009
Speaker will be Susie Justus, from Resmed, a major C-PAP manufacturer. She will explain in everyday language the problems and concerns you have using your C-PAP breathing apparatus and mask. (North County Times)
Resmed posts record revenue as US sales surge May 8, 2009
Sleep device maker Resmed has posted record revenue and income for the March quarter, driven by a surge in sales in the US but held back by a weaker performance in other parts of the world made worse by a decline in the value of other currencies against the greenback ... Resmed, which develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders, is listed on stock markets in both Australia and the United... (Sydney Morning Herald -- Business)
Swine flu booster for biotechs will fizzle May 1, 2009
Over time, as "pandemic'' is replaced on front pages by the next celebrity story, these stocks may well dwindle to levels close to pre-swine days. It's easy to understand why shareholders would seize the chance to rush for the exit on good terms. Biotechnology investors are long suffering with only a minority of companies ever delivering on commercialisation goals. Indeed, of the 130 life sciences companies listed on the ASX, just 20-odd are profitable; the biggest being CSL, Cochlear and... (Sydney Morning Herald -- Business)
Australia Stocks: AWB, David Jones, James Hardie Industries, ResMed, Rio Mar 18, 2009
Australia Stocks: Axa, David Jones, James Hardie, ResMed, Rio - Bloomberg ... Australia Stocks: Axa, David Jones, James Hardie, ResMed, Rio. (Bloomberg -- Australia & New Zealand)
Australia shares up 1.2 pct on miners; NAB, ANZ down Feb 7, 2009
Australia shares up 1. 2 pct on miners; NAB, ANZ down. (Ninemsn)
